Relja Popovic

9.8k citations
42 papers · 3.0k · 2 hit papers · h-index 23

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Multiple Myeloma Research and Treatments
    • Epigenetics and DNA Methylation
    • Histone Deacetylase Inhibitors Research
    • Protein Degradation and Inhibitors
    • Cancer-related gene regulation
    • Genomics and Chromatin Dynamics

Papers in

    • Epigenetics and DNA Methylation 13
    • Protein Degradation and Inhibitors 11
    • Histone Deacetylase Inhibitors Research 10
    • Genomics and Chromatin Dynamics 6
    • Cancer-related gene regulation 6
    • Acute Myeloid Leukemia Research 14
    • Multiple Myeloma Research and Treatments 8

Relja Popovic

39 papers receiving 3.0k citations

Relja Popovic's Hit Papers

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study 2019 · 462 citations
4620+2+5Years since publication100200300400500

Peers

Relja Popovic
Comparison fields: 5 of 92
  • Hematology 1.4k
  • Molecular Biology 2.1k
  • Genetics 278
  • Cancer Research 344
  • Oncology 331
Replace Peter Grauman with:
Peter Grauman United States
Fumihiko Hayakawa Japan
Christine M. McMahon United States
Brian A. Jonas United States
Paul M. Ayton United States
Heiko Becker Germany
Masayuki Towatari Japan
Sjozèf van Baal Netherlands
Étienne De Braekeleer France
Scott R. Daigle United States
Relja Popovic relative to Peter Grauman United States Peter Grauman's profile →
Citations per field
00.5×1.5×
Peter Grauman · 1×
Citations per year

Countries citing papers authored by Relja Popovic

Since Specialization
Citations

This map shows the geographic impact of Relja Popovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Relja Popovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Relja Popovic more than expected).

Fields of papers citing papers by Relja Popovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Relja Popovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Relja Popovic. The network helps show where Relja Popovic may publish in the future.

Co-authors

The 25 scholars most cited alongside Relja Popovic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Relja Popovic Line = papers co-authored together Relja Popovic links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
Hit paper breakdown →
2018508
2
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study
Hit paper breakdown →
2019462
3 2010277
4 2014184
5 2009172
6 2009145
7 2020133
8 2012130
9 2012101
10 201793
11 201293
12 200879
13 201574
14 200571
15 201270
16 201669
17 202153
18 200552
19 201749
20 201533

About Relja Popovic

Relja Popovic is a scholar working on Molecular Biology, Hematology, Genetics, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 3.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Epigenetics and DNA Methylation (13 papers), Protein Degradation and Inhibitors (11 papers), Histone Deacetylase Inhibitors Research (10 papers), Multiple Myeloma Research and Treatments (8 papers), Genomics and Chromatin Dynamics (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer-related gene regulation (6 papers). The work is most often cited by research in Hematology (1.4k citations), Molecular Biology (2.1k citations), Genetics (278 citations), Cancer Research (344 citations) and Oncology (331 citations). Relja Popovic has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Jonathan D. Licht, Nancy J. Zeleznik‐Le, Eva Martínez-García, Christine Will, Neil L. Kelleher, Brenda Chyla, Tu Xu, Andrew H. Wei, Suresh Agarwal and Rod Humerickhouse. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Cancer Research, Cell Reports and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact